Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Germline Genetic Testing Before and After a Medical Policy Covering Universal Testing Among Patients With Colorectal Cancer.
Moretz C, Byfield SD, Hatchell KE, Dalton J, Onglao PN, Hang L, Hansen P, Radford C, Nielsen SM, Heald B, Munro SB, Nussbaum RL, Esplin ED. Moretz C, et al. Among authors: esplin ed. JAMA Netw Open. 2022 Oct 3;5(10):e2238167. doi: 10.1001/jamanetworkopen.2022.38167. JAMA Netw Open. 2022. PMID: 36279135 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 37978112
Rate of Pathogenic Germline Variants in Patients With Lung Cancer.
Sorscher S, LoPiccolo J, Heald B, Chen E, Bristow SL, Michalski ST, Nielsen SM, Lacoste A, Keyder E, Lee H, Nussbaum RL, Martins R, Esplin ED. Sorscher S, et al. Among authors: esplin ed. JCO Precis Oncol. 2023 Sep;7:e2300190. doi: 10.1200/PO.23.00190. JCO Precis Oncol. 2023. PMID: 37992258 Free PMC article. Review.
Racial disparities in cascade testing for cancer predisposition genes.
Kassem NM, Althouse SK, Monahan PO, Hayes L, Nielsen SM, Heald B, Esplin ED, Hatchell KE, Ballinger TJ. Kassem NM, et al. Among authors: esplin ed. Prev Med. 2023 Jul;172:107539. doi: 10.1016/j.ypmed.2023.107539. Epub 2023 May 6. Prev Med. 2023. PMID: 37156429
Efficacy of National Comprehensive Cancer Network Guidelines in Identifying Pathogenic Germline Variants Among Unselected Patients with Prostate Cancer: The PROCLAIM Trial.
Shore N, Gazi M, Pieczonka C, Heron S, Modh R, Cahn D, Belkoff LH, Berger A, Mazzarella B, Veys J, Idom C, Morris D, Jayram G, Engelman A, Bukkapatnam R, Dato P, Bevan-Thomas R, Cornell R, Wise DR, Hardwick MK, Hernandez RD, Rojahn S, Layman P, Hatchell KE, Heald B, Nussbaum RL, Nielsen SM, Esplin ED. Shore N, et al. Among authors: esplin ed. Eur Urol Oncol. 2023 Oct;6(5):477-483. doi: 10.1016/j.euo.2023.07.008. Epub 2023 Aug 12. Eur Urol Oncol. 2023. PMID: 37574391 Free article.
96 results